New Research Reveals Disconnect Between Parents and Physicians in Pediatric Clinical Trial Recruitment
News Jun 25, 2013
Blue Chip Patient Recruitment, a global, full-service strategic marketing practice of Blue Chip Marketing Worldwide that specializes in accelerating enrollment of clinical trials, has announced results of its latest research study on how physicians and clinical trial coordinators can successfully accelerate enrollment of pediatric clinical trials.
The white paper, titled “Accelerating Recruitment for Pediatric Clinical Trials: Connecting Parents, Children and Investigators” and available at www.bcpatientrecruitment.com/whitepaper, summarizes the results of primary market research that explores the motivations and barriers a parent faces when considering clinical trial opportunities for their child and the challenges physicians experience when recruiting children for clinical trials.
“Understanding the true motivations and worries behind a parent’s decision to enroll their child in a clinical trial is essential for successful enrollment,” says Neil Weisman, EVP/general manager of Blue Chip Patient Recruitment. “With adult conditions starting to emerge in children more frequently and since many medications have never been studied in children, sponsors and investigators will need this type of research to successfully address changing pediatric healthcare needs.”
Key findings include:
The study shows that even though parents may be very or somewhat satisfied with their child’s current medication, physicians should always educate and inform parents of potential clinical trial opportunities. Nearly 85% of the parents who were “very or somewhat satisfied” with their child’s current medication indicated they would be willing to switching their child to a new medication option.
To better connect with parents, physicians should focus on how the trial can potentially benefit their child as opposed to more altruistic-based communications. More than 53% of parents cited “my child might benefit” as their top motivation for enrolling their child in a clinical trial while 74% of physicians chose “benefit other children in the future” as their main point when educating parents on clinical trial opportunities.
Physicians need to understand and create communications based on how their patients’ parents prefer to receive information about potential pediatric clinical trial opportunities. Listed as the most preferred method of communications, 46% of parents indicated they prefer to receive information about pediatric clinical trial opportunities from their physicians by email, whereas only 6% of physicians stated that email was the most effective way to communicate with parents. And while not one doctor stated a physical letter was effective, nearly 30% of parents preferred to receive clinical trial information via a physical letter.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE